Forward Pharma self-assured in 'giant rivalry'
Chairman of the Board Florian Schönharting believes that Forward Pharma’s drug candidate to treat psoriasis can topple rivals.
by Henrik Tüchsen
Denmark-based biotech company Forward Pharma, which is developing a biological drug to treat moderat-to-severe psoriasis, believes that the company’s candidate has a better profile than most of the drugs currently on the market.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler:
Danish biotech company considers global partnership
For abonnenter
